{"nct_id":"NCT00442650","title":"Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis","status":"COMPLETED","status_verified_date":"2009-03","start_date":"2004-01","start_date_type":null,"primary_completion_date":"2005-12","primary_completion_date_type":"ACTUAL","completion_date":"2005-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}